StockData
CYTOFOTCPharmaceutical PreparationsFiscal year ends December 31

Altamira Therapeutics Ltd.

Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2025
$0.09+0.00 (0.00%)

Close on Oct 19, 2026

Altamira Therapeutics Ltd. revenue by segment

No segment breakdown reported

Altamira Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.